Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Operating Expenses | 0 | 0 | 0 | 327 | 1,193 |
| Operating Income | N/A | 0 | 0 | -327 | -1,193 |
| Interest Expense | 0 | 0 | 0 | 667 | -7 |
| Other Income | 0 | 0 | 0 | 17 | -19 |
| Pre-tax Income | 0 | 0 | 0 | -977 | -1,205 |
| Net Income Continuous | N/A | 0 | 0 | -977 | -1,205 |
| Net Income | $N/A | $0 | $0 | $-977 | $-1,212 |
| EPS Basic Total Ops | N/A | N/A | N/A | -1.20 | -2.24 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | -1.17 | -2.34 |
| EPS Diluted Total Ops | N/A | N/A | N/A | -1.20 | -2.24 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | -1.17 | -2.34 |
| EBITDA(a) | $N/A | $0 | $0 | $-327 | $-1,193 |